Insulin therapy was analysed among 1260 type 1 or type 2 diabetic patients
during a national transversal survey. A total of 934 MDs, mostly diabetolog
ists, agreed to participate in this study, among which about half sent ques
tionnaire forms back. The number of different insulin therapy schemes was a
s high as 36, glucose control was not related with the number of shots. Usu
al management regarding injection and glucose self-monitoring is described
in this population which mostly relies on a diabetologist follow-up. One th
ird of patients featured an HbA1c < 7,5 %. Overall, glucose control remains
unsatisfactory and too many patients do not benefit from an optimized insu
lin therapy.